AI-Debiased Article
Rewritten from Fox News — Politics 1 min read
16 Public broadcaster provisional

ActBlue CEO to Testify Before House Committee Amid Fraud Investigation

Regina Wallace-Jones, CEO of ActBlue, will testify before the House Administration Committee regarding allegations of misleading Congress about donor fraud. The investigation focuses on ActBlue's practices for vetting overseas donations, which are generally prohibited in U.S. elections. The committee has expanded its inquiry to include interviews with board members and requested documents related to the organization's internal practices.

Companies
ActBlue
People
Regina Wallace-Jones Bryan Steil Jim Jordan James Comer

<p>Regina Wallace-Jones, the CEO of ActBlue, is scheduled to testify before the House Administration Committee regarding allegations that the organization misled Congress about donor fraud. This hearing is part of a congressional investigation into how ActBlue vets overseas donors.</p><p>This will be Wallace-Jones' first public response to the fraud allegations. ActBlue representatives have denied making false statements to Congress and have suggested that the investigation is politically motivated.</p><p>Wallace-Jones' attorney requested a subpoena for her testimony ahead of the hearing, which is set for June 10. Following a subpoena request from Republicans, she confirmed her attendance.</p><p>House Judiciary Committee Chairman Jim Jordan and House Oversight Committee Chairman James Comer are expected to participate in questioning Wallace-Jones during the hearing. Chairman Bryan Steil emphasized that the investigation aims to prevent foreign money from influencing U.S. elections.</p><p>The House Administration Committee has been examining ActBlue since 2023, focusing on the payment processor's fraud prevention practices and its handling of overseas donations, which are generally prohibited for political contributions. This scrutiny intensified after a report indicated that ActBlue's former legal counsel warned Wallace-Jones about potential false statements made to Congress regarding fraud screening practices.</p><p>Despite updating its donor screening practices, ActBlue did not correct its statements to the House Administration Committee until June 2025. The committee has also expanded its investigation to include interviews with ActBlue's Board of Directors regarding their response to congressional inquiries and internal issues within the organization.</p><p>Documents have been requested from the board members, who have until June 16 to comply.</p>

Annotating as

No note attached

on this article.

Bias Analysis

Bias score 16/100
wirepublicmainstream flavoredpartisanadvocacy
Inflammatory language 2/100

Bias Indicators Removed

  • loaded language: 'explosive'
  • vague attribution present

Original vs. Neutral

Original Headline

ActBlue chief heads to Capitol Hill hot seat as donor fraud probe intensifies

Neutral Headline

ActBlue CEO to Testify Before House Committee Amid Fraud Investigation

Pure Report assistant

Pure Report assistant

Article Q&A · read aloud
Assistant
I can read this article aloud or answer questions about it. What would you like to know?